Skip to content
← Enterprise AI

NeurOnstein

Alzheimer's Disease Reasoning

Parametric-knowledge-only hypothesis engine for Alzheimer's disease — challenge dominant assumptions, then propose falsifiable mechanisms from molecular to evolutionary scales.

Who it's forNeurodegeneration Researchers · Translational Scientists · Drug Discovery Teams

Researchers collaborating at a lab bench with microscope and laptop

What it does

  1. Assumption deconstruction
  2. Falsifiable hypothesis design
  3. Steelman counterarguments
  4. Cross-disciplinary synthesis

Built for

  1. AD researchers
  2. Translational neuroscientists
  3. Drug discovery teams
  4. Academic hypothesis labs

Value

  1. No literature retrieval
  2. Non-amyloid-centric reframes
  3. Experiment-ready predictions
  4. Confidence-calibrated output

How work changes

Same desk. Different first pass.

Traditional

Every page, every identifier, by hand.

  1. Out

    Literature review

  2. Out

    Manual hypothesis drafting

  3. Out

    Internal lab debate

  4. Out

    Design validation study

  5. Out

    Run experiments

  6. Out

    Iterate on findings

NeurOnstein

The model takes the first pass. People take the exceptions.

  1. Out

    Pose the biological question

  2. Out

    NeurOnstein deconstructs hidden assumptions

  3. Out

    Generates falsifiable hypotheses

  4. Out

    Steelmans strongest counterarguments

  5. Out

    Proposes realistic experimental tests

  6. Out

    Rates confidence level

Summarizing amyloid-centric narrativesInventing testable mechanisms worth experimentally challenging

Used for

Late-onset AD

Reframe vascular-metabolic, immune, and sleep hypotheses beyond default amyloid cascade framing.

Resilience anomalies

Mechanistic hypotheses for amyloid-positive elders who remain cognitively intact.

Multi-scale synthesis

Connect molecular, cellular, systems, metabolic, environmental, and evolutionary layers in one falsifiable claim.